Suppression of T cell stimulating function of allogeneic antigen presenting cells by Prodigiosin 25-C

Journal of Antibiotics

Volumn 51, Issue 1, 1998, Pages 92-94

  Yamashita, Masahiro ^a   Tsuji, Ryouhei F ^a   Yamasaki, Makari ^b   Kataoka, Takao ^b   Magae, Junji ^a   Nagai, Kazuo ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PRODIGIOSAN; PRODIGIOSIN 25C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBIOTIC BIOSYNTHESIS; ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ISOLATION; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031889170     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.92     Document Type: Article

References (25)

1. HARASHIMA, K.; N. TSUCHIDA, T. TANAKA & J. NAGATSU: Prodigiosin 25-C: Isolation and the chemical structure. Agric. Biol. Chem. 31: 481-489,1967
2. WASSERMAN, H. H.; G. C. RODGERS & D. D. KEITH: Undccylprodigiosin. Tetrahedron 32: 1851-19854,1976
3. NAKAMURA, A.; K. NAGAI, K. ANDO & G. TAMURA: Selective suppression by prodigiosin of the mitogenic response of murine splenocytes. J. Antibiotics 39: 1151-1159,1986
4. NAKAMURA, A.; J. MAGAE, R. F. TSUJI, M. YAMASAKI & K. NAGAI: Suppression of cytotoxic T cell induction in n'i'0 by prodigiosin 25-C. Transplantation 47:1013-1016, 1989
5. TSUJI, R. F.; J. MAGAE, M. YAMASHITA, K. NAGAI & M. YAMASAKI: Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells. J. Antibiotics 45: 1295-1302, 1992
6. BOWMAN, E. J.; A. SHIEBERS & K. ALTENDORF: Bafilomycins: a class of inhibitors of membrane ATPascs from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. U.S.A. 85: 7972-7976,1988 '
7. Woo, J.-T.; C. SHINOHARA, K. SAKAI, K. HASUMI & A. ENDO: Inhibition of the acidification of cndosomes and lysosomcs by the antibiotic concanamycin B in macrophage J774. Eur. J. Biochem. 207: 383-389,1992
8. KINASHI, H.; K. SOMENO & K. SAKAGUCHI: Isolation and characterization of concanamycin A, B and C. J. Antibiotics 37: 1333-1343,1984
9. KATAOKA, T.; J. MAGAE, H. NARIUCHI, M. YAMASAKI & K. NAGAI: Enhancement by concanavalin A of the supprcssivc effect of prodigiosin 25-C on proliferation of murine splenocytes. J. Antibiotics 45: 1303-1312, 1992
10. KATAOKA, T.; J. MAGAK, K. KASAMO, H. YAMANISHI, A. ENDO, M. YAMASAKI & K. NAGAI: Effects of prodigiosin 25-C on cultured cell lines: its similarity to monovalent polycthcr ionophorcs and vacuolar-type H+-ATPase inhibitors. J. Antibiotics 45: 1618-1625,1992
11. +-ATPase. Biosci. Biotech. Biochem. 59: 1417-142I,1995
12. KATAOKA, T.; K. TAKAKU, J. MAGAE, N. SHINOHARA, H. TAKAYAMA, S. KONDO & K. NAGAI: Acidification is essential for maintaining the structure and function of lytic granules of CTL. J. Immunol. 153: 3938-3947,1994
13. KATAOKA, T.; N. SHINOHARA, H. TAKAYAMA, K. TAKAKU, S. KONDO, S. YONKIIARA & K. NAGAI: Concanamycin A, a powerful tool for characterization and estimation of contribution of perform-and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156: 3678-3686,1996
14. KATAOKA, T.; M. MUROI, S. OIIKUMA, T. WARITANI, J. MAGAE, A. TAKATSUKI, S. KONDO, M. YAMASAKI & K. NAGAI: Prodigiosin 25-C uncouples vacuolar type H+ATPasc, inhibits vacuolar acidification and affects glycoprotcin processing. FEES Lett. 359: 53-59,1995
15. TSUJI, R. F.; M. YAMAMOTO, A. NAKAMURA, T. KATAOKA, J. MAGAE, K. NAGAI & M. YAMASAKI: Selective immunosuppression of prodigiosin 25-C and FK506 in the murine immune system. J. Antibiotics 43: 1293-1301, 1990
16. ITO, K.; T. KOBAYASHI, Y. MORIYAMA, K. TOSHIMA, K. TATSUTA, T. KAKIUCHI, M. FUTAI, H. L. PLOEGH & K. MIWA: Concanamycin B inhibits the expression of newly-synthesized MHC class II molecules on the cell surface. J. Antibiotics 48: 488-494,1995
17. GERMAIN, R. N. & D. M. MARGULIES: The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11: 403-450,1993
18. UNAKUE, E. R.: Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2: 395-428,1984
19. SINGER, A.; A. M. KRUISBEEK & P. M. ANDRYSIAK: T cell-accessory cell interactions that initiate allospccific cytotoxic T lymphocyte responses: existence of both la-restricted and la-unrestricted cellular interaction pathways. J. Immunol. 132: 2199-2209,1984
20. VIA, C. S.; G. C. TSOKOS, N. I. STOCKS, M. CLERICI & G. M. SHEARER: Human in vitro allogcncic responses: demonstration of three pathways of T helper cell activation. J. Immunol. 144: 2524-2528,1990
21. ROSENBERG, A. S. & A. SINGER: Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10: 333-358,1992
22. FUKUZAWA, M. & G. M. SHEARER: Effect of cyclosporin A on T cell immunity. I. Dose-dependent suppression of different murine T helper cell pathways. Eur. J. Immunol. 19:49-56,1989
23. CLERICI, M. & G. M. SHEARER: Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A. J. Immunol. 144: 2480-2485,1990
24. MAGAE, J.; M. M. MILLER, K. NAGAI & G. M. SHEARER: Effect of metacycloprodigiosin, an inhibitor of killer T cells, on murine skin and heart transplants. J. Antibiotics 49: 86-90,1996
25. MELLMAN, I.; R. FUCKS & A. HELHNIUS: Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55: 663-700,1986